Progress with alemtuzumab in chronic lymphocytic leukemia: Update from the 2003 Meeting of the American Society of Hematology

被引：3

|

作者：

Lee, D

机构：

来源：

CLINICAL LYMPHOMA | 2004年 / 4卷 / 04期

关键词：

D O I：

10.1016/S1526-9655(11)70036-7

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

收藏

页码：217 / 219

页数：3

相关论文

共 50 条

[21] Update and clinical highlights presented at the 2017 American Society of Hematology Meeting
Daniel Heintel
memo - Magazine of European Medical Oncology, 2018, 11 (2) : 84 - 84
[22] Update and clinical highlights presented at the 2017 American Society of Hematology Meeting
Heintel, Daniel
MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2018, 11 (02) : 84 - 84
[23] Alemtuzumab in the Treatment of Chronic Lymphocytic Leukemia
Tadeusz Robak
BioDrugs, 2005, 19 : 9 - 22
[24] Alemtuzumab in the treatment of chronic lymphocytic leukemia
Robak, T
BIODRUGS, 2005, 19 (01) : 9 - 22
[25] Acute myeloid leukemia—current data from the 2017 American Society of Hematology meeting
Pfeilstöcker M.
memo - Magazine of European Medical Oncology, 2018, 11 (2) : 97 - 100
[26] American Society of Hematology 2016 annual meeting: Progress in myelodysplastic syndromes
Pfeilstöcker M.
memo - Magazine of European Medical Oncology, 2017, 10 (2) : 58 - 61
[27] An Era comes to an End Findings in the Field of multiple Myeloma and chronic lymphocytic Leukemia from the 61st Annual Meeting of the American Society of Hematology (ASH 2019)
Habel, Christoph
ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (04) : 181 - 181
[28] AMERICAN-SOCIETY-OF-HEMATOLOGY MEETING
BAYNES, RD
LANCET, 1994, 344 (8939-4): : 1762 - 1763
[29] Highlights in Acute Lymphoblastic Leukemia From the 2013 American Society of Hematology Annual Meeting and Exposition
Advani, A. S.
Sanford, B.
Luger, S.
Devidas, M.
Larsen, E. C.
Liedtke, M.
Voorhees, P. M.
Foster, M. C.
Claxton, D. F.
Geyer, S.
Parker, E.
Coffan, K.
Carroll, W. L.
Winick, N. J.
Coutre, S. E.
Tallman, M. S.
Appelbaum, F. R.
Erba, H.
Stone, R. M.
Hunger, S. P.
Larson, R. A.
Stock, W.
Davila, M. L.
Riviere, I
Wang, X.
Bartido, S.
Stefanski, J.
He, Q.
Borquez-Ojeda, O.
Taylor, C.
Wasielewska, T.
Qu, J.
Bouhassira, D.
Bernal, Y. J.
Yoo, S.
Purdon, T.
Halton, E.
Quintanilla, H.
Park, J. H.
Curran, K. J.
Sadelain, M.
Brentjens, R. J.
Goekbuget, N. M.
Beck, J.
Brandt, K.
Brueggemann, M.
Burmeister, T.
Diedrich, H.
Faul, C.
Huettmann, A.
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2014, 12 (06) : 7 - 12
[30] The role of alemtuzumab in the treatment of chronic lymphocytic leukemia
Zent, Clive S.
LEUKEMIA & LYMPHOMA, 2008, 49 (02) : 175 - 176

← 1 2 3 4 5 →